Highlights

array(40) {
  [0]=>
  string(4) "2626"
  ["article_id"]=>
  string(4) "2626"
  [1]=>
  string(74) "How custom made implants have the potential to improve surgical procedures"
  ["article_title"]=>
  string(74) "How custom made implants have the potential to improve surgical procedures"
  [2]=>
  string(150) "The recent innovation of custom made implants has the potential to improve surgical procedures. The use of PolyEther Ether Ketone (PEEK) in these impl"
  ["short_description"]=>
  string(150) "The recent innovation of custom made implants has the potential to improve surgical procedures. The use of PolyEther Ether Ketone (PEEK) in these impl"
  [3]=>
  string(213) "The recent innovation of custom made implants has the potential to improve surgical procedures. The use of PolyEther Ether Ketone (PEEK) in these implants can play a key role in preventing post-surgical infection."
  ["description"]=>
  string(213) "The recent innovation of custom made implants has the potential to improve surgical procedures. The use of PolyEther Ether Ketone (PEEK) in these implants can play a key role in preventing post-surgical infection."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(68) "https://www.medicalplasticsnews.com/mpn-north-america/made-to-order/"
  ["blog_url"]=>
  string(68) "https://www.medicalplasticsnews.com/mpn-north-america/made-to-order/"
  [15]=>
  string(19) "2019-05-16 17:00:00"
  ["add_date"]=>
  string(19) "2019-05-16 17:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:19"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

How custom made implants have the potential to improve surgical procedures

The recent innovation of custom made implants has the potential to improve surgical procedures. The use of PolyEther Eth

array(40) {
  [0]=>
  string(4) "2485"
  ["article_id"]=>
  string(4) "2485"
  [1]=>
  string(104) "Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain"
  ["article_title"]=>
  string(104) "Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain"
  [2]=>
  string(150) "SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; "
  ["short_description"]=>
  string(150) "SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; "
  [3]=>
  string(251) "SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce the completion of its clinical..."
  ["description"]=>
  string(251) "SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce the completion of its clinical..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(274) "https://www.drugs.com/clinical_trials/veritas-announces-completion-clinical-trial-their-cannabis-product-acute-pain-18149.html?utm_source=ddc&utm_medium=rss&utm_campaign=Veritas+Announces+the+Completion+of+Clinical+Trial+on+their+Cannabis+Product+for+Treatment+of+Acute+Pain"
  ["blog_url"]=>
  string(274) "https://www.drugs.com/clinical_trials/veritas-announces-completion-clinical-trial-their-cannabis-product-acute-pain-18149.html?utm_source=ddc&utm_medium=rss&utm_campaign=Veritas+Announces+the+Completion+of+Clinical+Trial+on+their+Cannabis+Product+for+Treatment+of+Acute+Pain"
  [15]=>
  string(19) "2019-05-16 14:05:53"
  ["add_date"]=>
  string(19) "2019-05-16 14:05:53"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:33"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment

SAN JUAN, Puerto Rico, May 15, 2019 — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharm

array(40) {
  [0]=>
  string(4) "2531"
  ["article_id"]=>
  string(4) "2531"
  [1]=>
  string(122) "Terveystalo's network of occupational health services to expand: Terveystalo acquires Etelä-Karjalan Työkunto Oy"
  ["article_title"]=>
  string(122) "Terveystalo's network of occupational health services to expand: Terveystalo acquires Etelä-Karjalan Työkunto Oy"
  [2]=>
  string(25) "Press Release 16 May 2019"
  ["short_description"]=>
  string(25) "Press Release 16 May 2019"
  [3]=>
  string(36) "

Press Release 16 May 2019

" ["description"]=> string(36) "

Press Release 16 May 2019

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(192) "http://www.globenewswire.com/news-release/2019/05/16/1825803/0/en/Terveystalo-s-network-of-occupational-health-services-to-expand-Terveystalo-acquires-Etel%C3%A4-Karjalan-Ty%C3%B6kunto-Oy.html" ["blog_url"]=> string(192) "http://www.globenewswire.com/news-release/2019/05/16/1825803/0/en/Terveystalo-s-network-of-occupational-health-services-to-expand-Terveystalo-acquires-Etel%C3%A4-Karjalan-Ty%C3%B6kunto-Oy.html" [15]=> string(19) "2019-05-16 14:00:00" ["add_date"]=> string(19) "2019-05-16 14:00:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-23 14:23:48" ["create_at"]=> string(19) "2019-05-23 14:23:48" [19]=> string(0) "" ["slug"]=> string(0) "" }

Terveystalo's network of occupational health services to expand: Terveystalo acquires

Press Release 16 May 2019

array(40) {
  [0]=>
  string(4) "5288"
  ["article_id"]=>
  string(4) "5288"
  [1]=>
  string(57) "4th International Anesthesia and Pain Medicine Conference"
  ["article_title"]=>
  string(57) "4th International Anesthesia and Pain Medicine Conference"
  [2]=>
  string(150) "About the conference: It aims to accomplish and gather a well-proportioned group of anesthetic physicians, surgery specialists, nurses, research schol"
  ["short_description"]=>
  string(150) "About the conference: It aims to accomplish and gather a well-proportioned group of anesthetic physicians, surgery specialists, nurses, research schol"
  [3]=>
  string(512) "About the conference: It aims to accomplish and gather a well-proportioned group of anesthetic physicians, surgery specialists, nurses, research scholars, professors, delegates, students, speakers with an opportunity to develop the advanced technologies and terms in general anesthesia and methodologies in general surgery for improving health strategies. Anesthesia Meet 2019 will be organized with encompassing theme “A Passion for Better Medicine” and it is comprehend of 15 different scientifi..."
  ["description"]=>
  string(512) "About the conference: It aims to accomplish and gather a well-proportioned group of anesthetic physicians, surgery specialists, nurses, research scholars, professors, delegates, students, speakers with an opportunity to develop the advanced technologies and terms in general anesthesia and methodologies in general surgery for improving health strategies. Anesthesia Meet 2019 will be organized with encompassing theme “A Passion for Better Medicine” and it is comprehend of 15 different scientifi..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(89) "https://www.pharmiweb.com/event/4th-international-anesthesia-and-pain-medicine-conference"
  ["blog_url"]=>
  string(89) "https://www.pharmiweb.com/event/4th-international-anesthesia-and-pain-medicine-conference"
  [15]=>
  string(19) "2019-05-16 11:55:32"
  ["add_date"]=>
  string(19) "2019-05-16 11:55:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

4th International Anesthesia and Pain Medicine Conference

About the conference: It aims to accomplish and gather a well-proportioned group of anesthetic physicians, surgery speci

array(40) {
  [0]=>
  string(4) "4502"
  ["article_id"]=>
  string(4) "4502"
  [1]=>
  string(66) "SMi’s Pharmaceutical Cleanroom Technology Europe Conference"
  ["article_title"]=>
  string(66) "SMi’s Pharmaceutical Cleanroom Technology Europe Conference"
  [2]=>
  string(150) "SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, on the 9th and 10th October 2019 in London, UK."
  ["short_description"]=>
  string(150) "SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, on the 9th and 10th October 2019 in London, UK."
  [3]=>
  string(500) "SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals,..."
  ["description"]=>
  string(500) "SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(93) "https://www.pharmiweb.com/event/smi-s-pharmaceutical-cleanroom-technology-europe-conference-1"
  ["blog_url"]=>
  string(93) "https://www.pharmiweb.com/event/smi-s-pharmaceutical-cleanroom-technology-europe-conference-1"
  [15]=>
  string(19) "2019-05-16 09:50:12"
  ["add_date"]=>
  string(19) "2019-05-16 09:50:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

SMi’s Pharmaceutical Cleanroom Technology Europe Conference

SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, on the 9th and 10

array(40) {
  [0]=>
  string(4) "2470"
  ["article_id"]=>
  string(4) "2470"
  [1]=>
  string(164) "AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients"
  ["article_title"]=>
  string(164) "AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients"
  [2]=>
  string(150) "NORTH CHICAGO, Ill., May 15, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S"
  ["short_description"]=>
  string(150) "NORTH CHICAGO, Ill., May 15, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S"
  [3]=>
  string(245) "NORTH CHICAGO, Ill., May 15, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Venclexta (venetoclax) in combination with..."
  ["description"]=>
  string(245) "NORTH CHICAGO, Ill., May 15, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Venclexta (venetoclax) in combination with..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "8"
  ["rss_id"]=>
  string(1) "8"
  [14]=>
  string(300) "https://www.drugs.com/newdrugs/abbvie-announces-us-fda-approval-venclexta-venetoclax-chemotherapy-free-combination-regimen-4974.html?utm_source=ddc&utm_medium=rss&utm_campaign=AbbVie+Announces+US+FDA+Approval+of+Venclexta+%28venetoclax%29+as+a+Chemotherapy-Free+Combination+Regimen+for+Previously+Unt"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/newdrugs/abbvie-announces-us-fda-approval-venclexta-venetoclax-chemotherapy-free-combination-regimen-4974.html?utm_source=ddc&utm_medium=rss&utm_campaign=AbbVie+Announces+US+FDA+Approval+of+Venclexta+%28venetoclax%29+as+a+Chemotherapy-Free+Combination+Regimen+for+Previously+Unt"
  [15]=>
  string(19) "2019-05-16 07:05:27"
  ["add_date"]=>
  string(19) "2019-05-16 07:05:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:26"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:26"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combinat

NORTH CHICAGO, Ill., May 15, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company

array(40) {
  [0]=>
  string(4) "2486"
  ["article_id"]=>
  string(4) "2486"
  [1]=>
  string(200) "Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis"
  ["article_title"]=>
  string(200) "Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis"
  [2]=>
  string(150) "Wednesday, May 15, 2019 - Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a Phase 3 pivotal study (B7451012) evaluating the eff"
  ["short_description"]=>
  string(150) "Wednesday, May 15, 2019 - Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a Phase 3 pivotal study (B7451012) evaluating the eff"
  [3]=>
  string(242) "Wednesday, May 15, 2019 - Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a Phase 3 pivotal study (B7451012) evaluating the efficacy and safety of its investigational oral Janus kinase 1 (JAK1) inhibitor, abrocitinib..."
  ["description"]=>
  string(242) "Wednesday, May 15, 2019 - Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a Phase 3 pivotal study (B7451012) evaluating the efficacy and safety of its investigational oral Janus kinase 1 (JAK1) inhibitor, abrocitinib..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/pfizer-announces-positive-top-line-results-phase-3-study-investigational-oral-jak1-candidate-18151.html?utm_source=ddc&utm_medium=rss&utm_campaign=Pfizer+Announces+Positive+Top-Line+Results+from+Phase+3+Study+of+Investigational+Oral+JAK1+Candidate%2C+Abrocitinib"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/pfizer-announces-positive-top-line-results-phase-3-study-investigational-oral-jak1-candidate-18151.html?utm_source=ddc&utm_medium=rss&utm_campaign=Pfizer+Announces+Positive+Top-Line+Results+from+Phase+3+Study+of+Investigational+Oral+JAK1+Candidate%2C+Abrocitinib"
  [15]=>
  string(19) "2019-05-16 06:05:36"
  ["add_date"]=>
  string(19) "2019-05-16 06:05:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:34"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1

Wednesday, May 15, 2019 - Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a Phase 3 pivotal study

array(40) {
  [0]=>
  string(4) "2540"
  ["article_id"]=>
  string(4) "2540"
  [1]=>
  string(67) "The Cooper Companies to Present at  Jefferies Healthcare Conference"
  ["article_title"]=>
  string(67) "The Cooper Companies to Present at  Jefferies Healthcare Conference"
  [2]=>
  string(150) "PLEASANTON, Calif., May  15, 2019  (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the Jefferies Healthcare Conference in N"
  ["short_description"]=>
  string(150) "PLEASANTON, Calif., May  15, 2019  (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the Jefferies Healthcare Conference in N"
  [3]=>
  string(372) "

PLEASANTON, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the Jefferies Healthcare Conference in New York, NY, on June 4, 2019. Brian G. Andrews, Senior Vice President, Chief Financial Officer & Treasurer, will represent the Company in a presentation scheduled to begin at 2:00 PM ET.

" ["description"]=> string(372) "

PLEASANTON, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the Jefferies Healthcare Conference in New York, NY, on June 4, 2019. Brian G. Andrews, Senior Vice President, Chief Financial Officer & Treasurer, will represent the Company in a presentation scheduled to begin at 2:00 PM ET.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "27" ["rss_id"]=> string(2) "27" [14]=> string(137) "http://www.globenewswire.com/news-release/2019/05/15/1825624/0/en/The-Cooper-Companies-to-Present-at-Jefferies-Healthcare-Conference.html" ["blog_url"]=> string(137) "http://www.globenewswire.com/news-release/2019/05/15/1825624/0/en/The-Cooper-Companies-to-Present-at-Jefferies-Healthcare-Conference.html" [15]=> string(19) "2019-05-16 04:15:00" ["add_date"]=> string(19) "2019-05-16 04:15:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-23 14:23:54" ["create_at"]=> string(19) "2019-05-23 14:23:54" [19]=> string(0) "" ["slug"]=> string(0) "" }

The Cooper Companies to Present at Jefferies Healthcare Conference

PLEASANTON, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) wi

array(40) {
  [0]=>
  string(4) "2532"
  ["article_id"]=>
  string(4) "2532"
  [1]=>
  string(70) "Diversicare Wins Customer and Employee Approved Awards From NRC Health"
  ["article_title"]=>
  string(70) "Diversicare Wins Customer and Employee Approved Awards From NRC Health"
  [2]=>
  string(150) "BRENTWOOD, Tenn., May  15, 2019  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) has earned a 2019 Customer Approved Award an"
  ["short_description"]=>
  string(150) "BRENTWOOD, Tenn., May  15, 2019  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) has earned a 2019 Customer Approved Award an"
  [3]=>
  string(436) "

BRENTWOOD, Tenn., May 15, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) has earned a 2019 Customer Approved Award and a 2019 Employee Approved Award from Lincoln, Nebraska–based healthcare-intelligence firm NRC Health. The awards recognize senior-care organizations across the country for creating an outstanding care experience for their customers and employees.

" ["description"]=> string(436) "

BRENTWOOD, Tenn., May 15, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) has earned a 2019 Customer Approved Award and a 2019 Employee Approved Award from Lincoln, Nebraska–based healthcare-intelligence firm NRC Health. The awards recognize senior-care organizations across the country for creating an outstanding care experience for their customers and employees.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(141) "http://www.globenewswire.com/news-release/2019/05/15/1825535/0/en/Diversicare-Wins-Customer-and-Employee-Approved-Awards-From-NRC-Health.html" ["blog_url"]=> string(141) "http://www.globenewswire.com/news-release/2019/05/15/1825535/0/en/Diversicare-Wins-Customer-and-Employee-Approved-Awards-From-NRC-Health.html" [15]=> string(19) "2019-05-16 02:20:00" ["add_date"]=> string(19) "2019-05-16 02:20:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-23 14:23:48" ["create_at"]=> string(19) "2019-05-23 14:23:48" [19]=> string(0) "" ["slug"]=> string(0) "" }

Diversicare Wins Customer and Employee Approved Awards From NRC Health

BRENTWOOD, Tenn., May 15, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASD

array(40) {
  [0]=>
  string(4) "2659"
  ["article_id"]=>
  string(4) "2659"
  [1]=>
  string(67) "my interviewer was drinking a beer while sitting in a beanbag chair"
  ["article_title"]=>
  string(67) "my interviewer was drinking a beer while sitting in a beanbag chair"
  [2]=>
  string(150) "A reader writes: I have been on the job hunt for a while and have had numerous phone/in-person interviews for administrative assistant positions. I se"
  ["short_description"]=>
  string(150) "A reader writes: I have been on the job hunt for a while and have had numerous phone/in-person interviews for administrative assistant positions. I se"
  [3]=>
  string(1584) "

A reader writes: I have been on the job hunt for a while and have had numerous phone/in-person interviews for administrative assistant positions. I seem to struggle a little bit with my general overall presence during an interview (which has gotten better thanks to your tips!) but I am still having a hard time gauging […]

&#nl&#nl

my interviewer was drinking a beer while sitting in a beanbag chair was originally published by Alison Green on Ask a Manager.

&#nl" ["description"]=> string(1584) "

A reader writes: I have been on the job hunt for a while and have had numerous phone/in-person interviews for administrative assistant positions. I seem to struggle a little bit with my general overall presence during an interview (which has gotten better thanks to your tips!) but I am still having a hard time gauging […]

&#nl&#nl

my interviewer was drinking a beer while sitting in a beanbag chair was originally published by Alison Green on Ask a Manager.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "5" ["category"]=> string(1) "5" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "50" ["rss_id"]=> string(2) "50" [14]=> string(108) "https://www.askamanager.org/2019/05/my-interviewer-was-drinking-a-beer-while-sitting-in-a-beanbag-chair.html" ["blog_url"]=> string(108) "https://www.askamanager.org/2019/05/my-interviewer-was-drinking-a-beer-while-sitting-in-a-beanbag-chair.html" [15]=> string(19) "2019-05-16 01:59:57" ["add_date"]=> string(19) "2019-05-16 01:59:57" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-23 14:24:24" ["create_at"]=> string(19) "2019-05-23 14:24:24" [19]=> string(0) "" ["slug"]=> string(0) "" }

my interviewer was drinking a beer while sitting in a beanbag chair

A reader writes: I have been on the job hunt for a while and have had numerous phone/in-person interviews for adminis

array(40) {
  [0]=>
  string(4) "2533"
  ["article_id"]=>
  string(4) "2533"
  [1]=>
  string(118) "BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards"
  ["article_title"]=>
  string(118) "BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards"
  [2]=>
  string(150) "MALVERN, Pa., May  15, 2019  (GLOBE NEWSWIRE) -- BioTelemetry (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of "
  ["short_description"]=>
  string(150) "MALVERN, Pa., May  15, 2019  (GLOBE NEWSWIRE) -- BioTelemetry (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of "
  [3]=>
  string(437) "

MALVERN, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- BioTelemetry (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that Joseph H. Capper, President and CEO, has been awarded the 2019 Healthcare CEO of the Year Award by the Philadelphia Alliance for Capital and Technologies, or PACT.

" ["description"]=> string(437) "

MALVERN, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- BioTelemetry (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that Joseph H. Capper, President and CEO, has been awarded the 2019 Healthcare CEO of the Year Award by the Philadelphia Alliance for Capital and Technologies, or PACT.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(188) "http://www.globenewswire.com/news-release/2019/05/15/1825523/0/en/BioTelemetry-President-and-CEO-Joseph-H-Capper-Named-Healthcare-CEO-of-the-Year-at-26th-Annual-PACT-Enterprise-Awards.html" ["blog_url"]=> string(188) "http://www.globenewswire.com/news-release/2019/05/15/1825523/0/en/BioTelemetry-President-and-CEO-Joseph-H-Capper-Named-Healthcare-CEO-of-the-Year-at-26th-Annual-PACT-Enterprise-Awards.html" [15]=> string(19) "2019-05-16 01:52:00" ["add_date"]=> string(19) "2019-05-16 01:52:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-23 14:23:48" ["create_at"]=> string(19) "2019-05-23 14:23:48" [19]=> string(0) "" ["slug"]=> string(0) "" }

BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th A

MALVERN, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- BioTelemetry (NASDAQ:BEAT), the leading remote

array(40) {
  [0]=>
  string(4) "2660"
  ["article_id"]=>
  string(4) "2660"
  [1]=>
  string(55) "my boss won’t let me use any of my vacation time"
  ["article_title"]=>
  string(55) "my boss won’t let me use any of my vacation time"
  [2]=>
  string(150) "A reader writes: While my job lets me accrue paid time off for vacation, I seem to be in a position where any time I request time off I am denied by m"
  ["short_description"]=>
  string(150) "A reader writes: While my job lets me accrue paid time off for vacation, I seem to be in a position where any time I request time off I am denied by m"
  [3]=>
  string(1555) "

A reader writes: While my job lets me accrue paid time off for vacation, I seem to be in a position where any time I request time off I am denied by my manager. On the other hand, my manager takes vacation time off all the time. Am I missing something here? I have a […]

&#nl&#nl

my boss won’t let me use any of my vacation time was originally published by Alison Green on Ask a Manager.

&#nl" ["description"]=> string(1555) "

A reader writes: While my job lets me accrue paid time off for vacation, I seem to be in a position where any time I request time off I am denied by my manager. On the other hand, my manager takes vacation time off all the time. Am I missing something here? I have a […]

&#nl&#nl

my boss won’t let me use any of my vacation time was originally published by Alison Green on Ask a Manager.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "5" ["category"]=> string(1) "5" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "50" ["rss_id"]=> string(2) "50" [14]=> string(88) "https://www.askamanager.org/2019/05/my-boss-wont-let-me-use-any-of-my-vacation-time.html" ["blog_url"]=> string(88) "https://www.askamanager.org/2019/05/my-boss-wont-let-me-use-any-of-my-vacation-time.html" [15]=> string(19) "2019-05-16 00:29:47" ["add_date"]=> string(19) "2019-05-16 00:29:47" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-23 14:24:24" ["create_at"]=> string(19) "2019-05-23 14:24:24" [19]=> string(0) "" ["slug"]=> string(0) "" }

my boss won’t let me use any of my vacation time

A reader writes: While my job lets me accrue paid time off for vacation, I seem to be in a position where any time I